Abstract Details
|
Amanda L. Piquet, MD, FAAN
(University of Colorado)
PRESENTER |
The institution of Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech/Roche. The institution of Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. The institution of Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Kyverna . The institution of Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech/Roche. The institution of Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyverna. The institution of Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Sands Anderson PC. Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Joe Jones Law Firm. Dr. Piquet has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Cortez & Associates. Dr. Piquet has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Falk Waas. The institution of Dr. Piquet has received research support from Rocky Mountain MS Center. The institution of Dr. Piquet has received research support from Roche/Genentech. The institution of Dr. Piquet has received research support from NYU. The institution of Dr. Piquet has received research support from Anokion. The institution of Dr. Piquet has received research support from UCB . The institution of Dr. Piquet has received research support from Foundation for Sarcoidosis. The institution of Dr. Piquet has received research support from Kyverna . Dr. Piquet has received publishing royalties from a publication relating to health care. Dr. Piquet has received publishing royalties from a publication relating to health care. Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving as a Litigative Consultant with US-Dept HHS/DICP. Dr. Piquet has a non-compensated relationship as a Medical Advisory Board Member with Autoimmune Encephalitis Alliance (AEA) that is relevant to AAN interests or activities. Dr. Piquet has a non-compensated relationship as a Medical Advisory Board Member with Stiff Person Syndrome Research Foundation (SPSRF) that is relevant to AAN interests or activities. |
| Anastasia Zekeridou, MD, PhD, FAAN (Neuroimmunology Laboratory, Mayo Clinic) | The institution of Dr. Zekeridou has received research support from Roche/Genentech. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care. |
| Usama Gergis, MD | Prof. Gergis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyverna. Prof. Gergis has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. Prof. Gergis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Autolus. Prof. Gergis has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Incyte. Prof. Gergis has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Kite. Prof. Gergis has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Merck. Prof. Gergis has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Jazz. |
| Jonathan Gutman | No disclosure on file |
| Saad Kenderian, MD | Prof. Kenderian has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis, Kite, Capstan, Luminary, Humanigen/Taran. Prof. Kenderian has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Carisma, Humanigen/Taran . The institution of Prof. Kenderian has received research support from Kite/Gilead, Novartis. BMS, Lentigen, Tolero/Sumitomo, Sunesis/Viracta, LeahLabs, Morphosys. Prof. Kenderian has received intellectual property interests from a discovery or technology relating to health care. |
| Mallory Lowe, MD | Dr. Lowe has received research support from Kyverna Therapeutics. |
| Sadie Eggmann | Sadie Eggmann has nothing to disclose. |
| Andrew McKeon, MD (Mayo Clinic) | The institution of Dr. McKeon has received research support from National Institutes of Health. Dr. McKeon has received intellectual property interests from a discovery or technology relating to health care. Dr. McKeon has received intellectual property interests from a discovery or technology relating to health care. Dr. McKeon has received publishing royalties from a publication relating to health care. |
| Sean J. Pittock, MD, FAAN (Mayo Clinic Dept of Neurology) | Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. The institution of Dr. Pittock has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion/AstraZeneka. The institution of Dr. Pittock has received research support from NIH. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received publishing royalties from a publication relating to health care. |
| Goran Rakocevic, MD, FAAN (Thomas Jefferson University) | Dr. Rakocevic has nothing to disclose. |
| Jessica Yi, MD (Thomas Jefferson University, Department of Neurology) | Dr. Yi has nothing to disclose. |
| Scott D. Newsome, DO, FAAN (Johns Hopkins Hospital) | Dr. Newsome has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Newsome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Newsome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. The institution of Dr. Newsome has received research support from Biogen. The institution of Dr. Newsome has received research support from Genentech/Roche. The institution of Dr. Newsome has received research support from Department of Defense. The institution of Dr. Newsome has received research support from Patient Centered Outcomes Research Institute. The institution of Dr. Newsome has received research support from National MS Society. The institution of Dr. Newsome has received research support from Lundbeck. The institution of Dr. Newsome has received research support from Sanofi. The institution of Dr. Newsome has received research support from Kyverna Therapeutics. Dr. Newsome has received personal compensation in the range of $10,000-$49,999 for serving as a Lead PI for Clinical Trial with Roche. |
| Justin Chou, PhD | Dr. Chou has received personal compensation for serving as an employee of Kyverna Therapeutics. Dr. Chou has received intellectual property interests from a discovery or technology relating to health care. |
| Tom Van Blarcom, PhD | Dr. Van Blarcom has received personal compensation for serving as an employee of Kyverna Therapeutics. Dr. Van Blarcom has stock in Kyverna Therapeutics. Dr. Van Blarcom has stock in Allogene Theraepeutics. |
| Xue Han | No disclosure on file |
| John Sun, PhD | Dr. Sun has received personal compensation for serving as an employee of Kyverna Therapeutics, Inc. |
| Shouvonik Sengupta, PhD | Dr. Sengupta has received personal compensation for serving as an employee of Kyverna Therapeutics. Dr. Sengupta has or had stock in Kyverna Therapeutics. An immediate family member of Dr. Sengupta has or had stock in Kyverna Therapeutics. |
| Ryan Tooker | Dr. Tooker has received personal compensation for serving as an employee of Prothena Biosciences, Inc. Dr. Tooker has received personal compensation for serving as an employee of Kyverna Therapeutics, Inc. Dr. Tooker has or had stock in Prothena Biosciences, Inc.Dr. Tooker has or had stock in Kyverna Therapeutics, Inc. |
| Aditi Mehta | Dr. Mehta has received personal compensation for serving as an employee of Kyverna Therapeutics. Dr. Mehta has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Atara Biotherapeutics. Dr. Mehta has or had stock in Kyverna Therapeutics.Dr. Mehta has or had stock in Atara Biotherapeutics. |
| Dena Grayson | Dr. Grayson has received personal compensation for serving as an employee of Kyverna Therapeutics. |
| Naji Gehchan | Dr. Gehchan has received personal compensation for serving as an employee of Kyverna Tx. Dr. Gehchan has received personal compensation for serving as an employee of Eli Lilly. Dr. Gehchan has stock in Eli Lilly. |
| Marinos C. Dalakas, MD, FAAN (Thomas Jefferson University) | Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grifols, . Dr. Dalakas has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Dysimmune Diseases Foundation. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octapharma. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ARGENX. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Therapeutic Advances in Neurology (TAND). Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medlink. |